Journal of Clinical Endocrinology & Metabolism, Vol 81, 1548-1551, Copyright © 1996 by Endocrine Society

ARTICLES

Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas

D Russo, F Arturi, HG Suarez, M Schlumberger, JA Du Villard, U Crocetti and S Filetti
Dipartimento di Medicina Sperimentale e Clinica, Catanzaro, Italy.

Forty-four thyroid autonomously hyperfunctioning adenomas were analyzed to assess the frequency of mutations occurring in the TSH receptor (TSHR). PCR-amplified fragments encompassing the entire exon 10 of the TSHR gene were obtained from the genomic DNA extracted from the tumors and their adjacent normal tissues and were examined by direct nucleotide sequencing. Point mutations were found in 9 of the 44 adenomas examined (20%). One mutation occurred in codon 619 (Asp to Gly), four in codon 623 (three were Ala to Ser, one Ala to Val substitution), two in codon 632 (both Thr to Ile), and two in codon 633 (Asp to Tyr or His). All the alterations were located in a part of the gene coding for an area including the third intracellular loop and the sixth transmembrane domain of the TSH receptor. All mutations were somatic and heterozygotic, and none was simultaneous with alterations of ras or gsp oncogenes. Thus, our data show that in our series of 44 hyperfunctioning thyroid adenomas, a somatic mutation of the TSHR, responsible for the constitutive activation of the cAMP pathway, occurs in 20% of the tumors.

This article has been cited by other articles:

				S.-C. Ho, S.-S. Goh, I. H C Kee, P. K H Chow, C.-P. Yeo, and D. H C Khoo Effects of genetic immunization of Swiss outbred mice with human thyroid stimulating hormone receptor cDNA plasmids harboring gain-of-function mutations J. Mol. Endocrinol., February 1, 2007; 38(2): 277 - 288. [Abstract] [Full Text] [PDF]

				H. I. Gozu, R. Bircan, K. Krohn, S. Muller, S. Vural, C. Gezen, H. Sargin, D. Yavuzer, M. Sargin, B. Cirakoglu, et al. Similar prevalence of somatic TSH receptor and Gs{alpha} mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur. J. Endocrinol., October 1, 2006; 155(4): 535 - 545. [Abstract] [Full Text] [PDF]

				S G Watson, A D Radford, A Kipar, P Ibarrola, and L Blackwood Somatic mutations of the thyroid-stimulating hormone receptor gene in feline hyperthyroidism: parallels with human hyperthyroidism J. Endocrinol., September 1, 2005; 186(3): 523 - 537. [Abstract] [Full Text] [PDF]

				K. Krohn, D. Fuhrer, Y. Bayer, M. Eszlinger, V. Brauer, S. Neumann, and R. Paschke Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter Endocr. Rev., June 1, 2005; 26(4): 504 - 524. [Abstract] [Full Text] [PDF]

				C. Als, P. Gedeon, H. Rosler, C. Minder, P. Netzer, and J. A. Laissue Survival Analysis of 19 Patients with Toxic Thyroid Carcinoma J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4122 - 4127. [Abstract] [Full Text] [PDF]

				S. Neumann, G. Krause, S. Chey, and R. Paschke A Free Carboxylate Oxygen in the Side Chain of Position 674 in Transmembrane Domain 7 Is Necessary for TSH Receptor Activation Mol. Endocrinol., August 1, 2001; 15(8): 1294 - 1305. [Abstract] [Full Text] [PDF]

				K. Krohn and R. Paschke Progress in Understanding the Etiology of Thyroid Autonomy J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3336 - 3345. [Full Text] [PDF]

				S. Y. Hsu, M. Kudo, T. Chen, K. Nakabayashi, A. Bhalla, P. J. van der Spek, M. van Duin, and A. J. W. Hsueh The Three Subfamilies of Leucine-Rich Repeat-Containing G Protein-Coupled Receptors (LGR): Identification of LGR6 and LGR7 and the Signaling Mechanism for LGR7 Mol. Endocrinol., August 1, 2000; 14(8): 1257 - 1271. [Abstract] [Full Text]

				M. Tonacchera, P. Agretti, L. Chiovato, V. Rosellini, G. Ceccarini, A. Perri, P. Viacava, A. G. Naccarato, P. Miccoli, A. Pinchera, et al. Activating Thyrotropin Receptor Mutations Are Present in Nonadenomatous Hyperfunctioning Nodules of Toxic or Autonomous Multinodular Goiter J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2270 - 2274. [Abstract] [Full Text]

				A. Brunetti, E. Chiefari, S. Filetti, and D. Russo The 3',5'-Cyclic Adenosine Monophosphate Response Element Binding Protein (CREB) Is Functionally Reduced in Human Toxic Thyroid Adenomas Endocrinology, February 1, 2000; 141(2): 722 - 730. [Abstract] [Full Text] [PDF]

				M. Tonacchera, P. Vitti, P. Agretti, G. Ceccarini, A. Perri, R. Cavaliere, B. Mazzi, A. G. Naccarato, P. Viacava, P. Miccoli, et al. Functioning and Nonfunctioning Thyroid Adenomas Involve Different Molecular Pathogenetic Mechanisms J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4155 - 4158. [Abstract] [Full Text]

				E. M. Gabriel, E. R. Bergert, C. S. Grant, J. A. van Heerden, G. B. Thompson, and J. C. Morris Germline Polymorphism of Codon 727 of Human Thyroid-Stimulating Hormone Receptor Is Associated with Toxic Multinodular Goiter J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3328 - 3335. [Abstract] [Full Text]

				A. Schulz, T. Schöneberg, R. Paschke, G. Schultz, and T. Gudermann Role of the Third Intracellular Loop for the Activation of Gonadotropin Receptors Mol. Endocrinol., February 1, 1999; 13(2): 181 - 190. [Abstract] [Full Text]

				M. Tonacchera, L. Chiovato, A. Pinchera, P. Agretti, E. Fiore, F. Cetani, R. Rocchi, P. Viacava, P. Miccoli, and P. Vitti Hyperfunctioning Thyroid Nodules in Toxic Multinodular Goiter Share Activating Thyrotropin Receptor Mutations with Solitary Toxic Adenoma J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 492 - 498. [Abstract] [Full Text]

				M. D. Ringel, M. Saji, W. F. Schwindinger, D. Segev, M. A. Zeiger, and M. A. Levine Absence of Activating Mutations of the Genes Encoding the {alpha}-Subunits of G11 and Gq in Thyroid Neoplasia J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 554 - 559. [Abstract] [Full Text]

				R. Paschke and M. Ludgate The Thyrotropin Receptor in Thyroid Diseases N. Engl. J. Med., December 4, 1997; 337(23): 1675 - 1681. [Full Text] [PDF]

				D. Fuhrer, H.-P. Holzapfel, P. Wonerow, W. A. Scherbaum, and R. Paschke Somatic Mutations in the Thyrotropin Receptor Gene and Not in the Gs{alpha} Protein Gene in 31 Toxic Thyroid Nodules J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3885 - 3891. [Abstract] [Full Text] [PDF]

				J. Parma, L. Duprez, J. Van Sande, J. Hermans, P. Rocmans, G. Van Vliet, S. Costagliola, P. Rodien, J. E. Dumont, and G. Vassart Diversity and Prevalence of Somatic Mutations in the Thyrotropin Receptor and Gs{alpha} Genes as a Cause of Toxic Thyroid Adenomas J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2695 - 2701. [Abstract] [Full Text] [PDF]

				M. Ivan, M. Ludgate, V. Gire, J. A. Bond, and D. Wynford-Thomas An Amphotropic Retroviral Vector Expressing a Mutant gsp Oncogene: Effects on Human Thyroid Cells in Vitro J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2702 - 2709. [Abstract] [Full Text] [PDF]

				R. J. Clifton-Bligh, J. W. Gregory, M. Ludgate, R. John, L. Persani, C. Asteria, P. Beck-Peccoz, and V. K. K. Chatterjee Two Novel Mutations in the Thyrotropin (TSH) Receptor Gene in a Child with Resistance to TSH J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1094 - 1100. [Abstract] [Full Text] [PDF]

				D. Russo, S. Tumino, F. Arturi, P. Vigneri, G. Grasso, A. Pontecorvi, S. Filetti, and A. Belfiore Detection of an Activating Mutation of the Thyrotropin Receptor in a Case of an Autonomously Hyperfunctioning Thyroid Insular Carcinoma J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 735 - 738. [Abstract] [Full Text] [PDF]